CULLEN INVESTMENT GROUP, LTD.

Position in GILD — Gilead Sciences, Inc.

CIK 797203 LAFAYETTE, LA

Position in GILD

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$1,608,308

-$160,436 QoQ

Shares Held

12,730

+0.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#901

of 2,266 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CULLEN INVESTMENT GROUP, LTD. holds $51,757,200 across 9 Drug Manufacturers - General names. GILD ranks #7 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	110,982	$14,261,187
2	LLY	ELI LILLY & Co	11,647	$13,969,762
3	NVS	Novartis AG	55,534	$8,703,288
4	JNJ	Johnson & Johnson	24,881	$6,319,027
5	ABBV	AbbVie Inc.	12,865	$3,237,348
6	AMGN	Amgen Inc	7,730	$2,799,187
7	GILD	Gilead Sciences, Inc. This page	12,730	$1,608,308
8	NVO	Novo Nordisk A S	10,000	$479,400

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,608,308	12,730	+0.3%	Shares	Sole	2026-07-09
2026-03-31	$1,768,744	12,691	-1.3%	Shares	Sole	2026-04-09
2025-12-31	$1,578,436	12,860	-1.5%	Shares	Sole	2026-01-12
2025-09-30	$1,449,327	13,057	-6.7%	Shares	Sole	2025-10-07
2025-06-30	$1,551,847	13,997	-4.0%	Shares	Sole	2025-07-01
2025-03-31	$1,633,464	14,578	-7.8%	Shares	Sole	2025-04-01
2024-12-31	$1,460,184	15,808	-3.2%	Shares	Sole	2025-01-13
2024-09-30	$1,368,520	16,323	-6.6%	Shares	Sole	2024-10-04
2024-06-30	$1,198,891	17,474	-6.3%	Shares	Sole	2024-07-01
2024-03-31	$1,365,453	18,641	-6.3%	Shares	Sole	2024-04-04
2023-12-31	$1,610,802	19,884	—	Shares	Sole	2024-01-30
No filing history on record for this holder in this stock.